# XORTX Therapeutics Inc.: Form 6-K, filed Oct 8, 2026

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2026-10-08
- Accepted by EDGAR: Oct 8, 2026, 20:07 ET
- Period: 2026-10-08
- Accession: 0001171843-26-006540
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184326006540/f6k_100826.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184326006540/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184326006540/f6k_100826.htm

Filed Oct 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-006540. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.